Adherence to antihypertensive drug treatment in patients with apparently treatment-resistant hypertension in the INSPiRED pilot study

Adherence to antihypertensive drug treatment in patients with apparently treatment-resistant hypertension in the INSPiRED pilot study

Purpose: Drug adherence may be a major problem in the therapy of hypertension and in the diagnosis of therapy resistance. Adherence can be assessed by indirect methods or by direct methods like drug detection in urine with liquid chromatography-mass spectrometric methods. Materials and methods: The...

Full description

Bibliographic Details
Main Authors: Cora Wunder, Alexandre Persu, Jean-Philippe Lengelé, Coralie MG Georges, Jean Renkin, Agnès Pasquet, Marc Carlier, Zhen-Yu Zhang, Jan A. Staessen, The European Network Coordinating Research on Renal Denervation (ENCOReD), Stefan W. Toennes
Format: Article
Language:English
Published: Taylor & Francis Group 2019-05-01
Series:Blood Pressure
Subjects:
compliance
resistant hypertension
toxicological analysis
antihypertensive drugs
renal denervation
Online Access:http://dx.doi.org/10.1080/08037051.2019.1599814
Description
Summary:Purpose: Drug adherence may be a major problem in the therapy of hypertension and in the diagnosis of therapy resistance. Adherence can be assessed by indirect methods or by direct methods like drug detection in urine with liquid chromatography-mass spectrometric methods. Materials and methods: The current analysis included patients with apparently treatment- resistant hypertension (TRH) referred for renal denervation (RDN) and included in the the INSPiRED pilot trial (NCT 01505010). Adherence was repeatedly assessed by toxicological urine analysis over a time range of up to 17 months in a total of 18 patients. Results: In the first urine samples of 18 patients the adherence rate (percentage of number of detected vs. prescribed medical drugs) ranged from 0 to 100% with a median of 73.2%. In further urine samples collected during the following up to 17 months every individual patient exhibited considerable changes in the adherence rate, neither a constancy nor a tendency could be deduced. Conclusions: Urine analysis results exhibit variation over time and an assessment at a certain time point cannot be regarded as representative or predictor for future behavior. Therefore, it appears necessary to perform drug adherence testing repeatedly over time. Trial registration: ClinicalTrials.gov identifier: NCT01505010.
ISSN:0803-7051
1651-1999

Similar Items